CEACAM5 and neoplasm: We assessed the levels of CXCL12 and CXCR4 in the sera of 49 OC patients, considering the clinicopathological characteristics and comparing them with classical tumor markers (SCC-Ag and CEA) and markers of inflammation—CRP.